A novel antibiotic drug showed similar treatment effectiveness compared to current therapies in patients with antibiotic resistant bacterial infections, according to two complementary clinical trials.
Menu
Browsing: Patient Care
A novel drug may improve the efficacy of corticosteroid treatment for patients with Duchenne muscular dystrophy and overall quality of life, according to a recent clinical trial.
In the face of the greatest public health crisis in a century, Feinberg’s Institute for Public Health and Medicine (IPHAM) mobilized with leading-edge science, new grant programs for community partners and a series of informational webinars.
A brief course of immunotherapy resulted in complete and near complete remission in nearly two-thirds of previously untreated patients with classical Hodgkin lymphoma, according to a Northwestern Medicine trial.
Measuring acid reflux with a wireless electrode can help clinicians determine if patients can stop taking proton pump inhibitors, a medication commonly prescribed for gastroesophageal reflux disease.
The impact of COVID-19 on cancer patients has been a stark reality for many cancer centers around the world. For the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a combination of time and dedication to patient care and research has resulted in the development of robust COVID-19 testing protocols to ensure the safety and health of every patient, physician and staff member.
A first of its kind drug called vosoritide may increase bone growth in children with achondroplasia, the most common form of dwarfism, according to findings from a recent clinical trial.
A nationwide clinical trial has found that patients taking antibiotics for appendicitis reported the same quality of life measures as those who underwent surgery.
Northwestern investigators have developed a novel vaccine that utilizes a specialized group of B-cells to promote anti-tumor immunity against glioblastoma.
Lifestyle advice has been only somewhat effective in controlling or slowing the progression of nonalcoholic fatty liver disease in children, according to a recent study published in Gastroenterology.